| 251 | PBYIPuma Biotechnology, Inc. |
$228.4M |
13.6% |
2025 |
| 252 | AXGNAxogen, Inc. |
$225.2M |
-7.0% |
2025 |
| 253 | IDYAIDEAYA Biosciences, Inc. |
$218.7M |
-52.0% |
2025 |
| 254 | VNDAVanda Pharmaceuticals Inc. |
$216.1M |
-102.0% |
2025 |
| 255 | AMRNAmarin Corp PLC |
$213.6M |
-18.2% |
2025 |
| 256 | TMCITreace Medical Concepts, Inc. |
$212.7M |
-27.7% |
2025 |
| 257 | ESTAEstablishment Labs Holdings Inc. |
$211.1M |
-24.2% |
2025 |
| 258 | SIBNSI-BONE, Inc. |
$200.9M |
-9.4% |
2025 |
| 259 | SRTAStrata Critical Medical, Inc. |
$197.1M |
21.0% |
2025 |
| 260 | LFMDPLifeMD, Inc. |
$194.1M |
7.4% |
2025 |
| 261 | CRONCronos Group Inc. |
$193.4M |
-4.9% |
2025 |
| 262 | LAKELakeland Industries Inc |
$192.6M |
-13.1% |
2026 |
| 263 | BTMDbiote Corp. |
$192.2M |
14.1% |
2025 |
| 264 | RYTMRhythm Pharmaceuticals, Inc. |
$189.8M |
-103.6% |
2025 |
| 265 | MRVIMaravai Lifesciences Holdings, Inc. |
$185.7M |
-70.4% |
2025 |
| 266 | STOKStoke Therapeutics, Inc. |
$184.4M |
-3.7% |
2025 |
| 267 | LFVNLifevantage Corp |
$182.6M |
2.8% |
2026 |
| 268 | GLASGlass House Brands Inc. |
$182M |
-16.3% |
2025 |
| 269 | KMDAKamada Ltd |
$180.5M |
11.2% |
2025 |
| 270 | CYRXCryoport, Inc. |
$176.2M |
44.4% |
2025 |
| 271 | HTFLHeartflow, Inc. |
$176M |
-66.3% |
2025 |
| 272 | PHATPhathom Pharmaceuticals, Inc. |
$175.1M |
-126.3% |
2025 |
| 273 | VALNValneva SE |
€174.7M |
-66.0% |
2025 |
| 274 | SBCSBC Medical Group Holdings Inc |
$173.6M |
29.4% |
2025 |
| 275 | SNDXSyndax Pharmaceuticals Inc |
$172.4M |
-165.6% |
2025 |
| 276 | RGNXREGENXBIO Inc. |
$170.4M |
-113.8% |
2025 |
| 277 | OGIOrganigram Global Inc. |
CA$159.8M |
-28.4% |
2024 |
| 278 | LQDALiquidia Corp |
$158.3M |
-43.5% |
2025 |
| 279 | HRTXHeron Therapeutics, Inc. |
$154.9M |
-13.0% |
2025 |
| 280 | AIRSAirsculpt Technologies, Inc. |
$151.8M |
-7.7% |
2025 |
| 281 | MGNXMacrogenics Inc |
$149.5M |
-49.9% |
2025 |
| 282 | STIMNeuronetics, Inc. |
$149.2M |
-26.1% |
2025 |
| 283 | GRALGRAIL, Inc. |
$147.2M |
-277.5% |
2025 |
| 284 | KPTIKaryopharm Therapeutics Inc. |
$146.1M |
-134.2% |
2025 |
| 285 | INFUInfuSystem Holdings, Inc |
$143.4M |
4.6% |
2025 |
| 286 | BEAMBeam Therapeutics Inc. |
$139.7M |
-57.2% |
2025 |
| 287 | NRCNrc Health |
$137.4M |
8.2% |
2025 |
| 288 | RXSTRxSight, Inc. |
$134.5M |
-29.0% |
2025 |
| 289 | AAPGAscentage Pharma Group International |
$134.3M |
-41.3% |
2024 |
| 290 | XTNTXtant Medical Holdings, Inc. |
$133.9M |
3.7% |
2025 |
| 291 | NAGENiagen Bioscience, Inc. |
$129.4M |
13.4% |
2025 |
| 292 | LFCRLifecore Biomedical, Inc. DE |
$128.9M |
-30.0% |
2025 |
| 293 | XNCRXencor Inc |
$125.6M |
-73.2% |
2025 |
| 294 | GLUEMonte Rosa Therapeutics, Inc. |
$123.7M |
-31.2% |
2025 |
| 295 | ATRAAtara Biotherapeutics, Inc. |
$120.8M |
27.1% |
2025 |
| 296 | OMOutset Medical, Inc. |
$119.5M |
-68.3% |
2025 |
| 297 | GYREGyre Therapeutics, Inc. |
$116.6M |
8.5% |
2025 |
| 298 | OSUROrasure Technologies Inc |
$115M |
-59.8% |
2025 |
| 299 | AGENAgenus Inc |
$114.2M |
-0.1% |
2025 |
| 300 | IBRXImmunityBio, Inc. |
$113.3M |
-310.2% |
2025 |